FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1930217809> ?p ?o ?g. }

• W1930217809 abstract "Background The efficacy of chlorpromazine, a benchmark antipsychotic, has not been fully assessed in direct comparison with different individual antipsychotics. Penfluridol is another old antipsychotic with a long half‐life so one oral dose may last up to one week. This could confer advantage. Objectives To assess the clinical effects of chlorpromazine compared with penfluridol for adults with schizophrenia. Search methods On 31 March 2017, we searched the Cochrane Schizophrenia Group’s Study‐Based Register of Trials which is based on regular searches of CINAHL, BIOSIS, AMED, Embase, PubMed, MEDLINE, PsycINFO, and registries of clinical trials. There are no language, date, document type, or publication status limitations for inclusion of records in the register. Selection criteria We included all randomised clinical trials focusing on chlorpromazine versus penfluridol for adults with schizophrenia or related disorders. Outcomes of interest were death, service utilisation, global state, mental state, adverse effects and leaving the study early. We included trials meeting our selection criteria and reporting useable data. Data collection and analysis We extracted data independently. For binary outcomes, we calculated risk ratio (RR) and its 95% confidence interval (CI), on an intention‐to‐treat basis. For continuous data, we planned to estimate the mean difference (MD) between groups and its 95% CI. We employed a fixed‐effect model for analyses. We assessed risk of bias for included studies and created a 'Summary of findings' table using GRADE. Main results The review includes three studies with a total of 130 participants. Short‐term results for hospital admissions showed no clear difference between chlorpromazine and penfluridol (1 RCT, n = 29, RR 0.19, 95% CI 0.01 to 3.60, low‐quality evidence). No clear difference in the incidence of akathisia was found at medium term (2 RCTs, n = 85, RR 0.19, 95% CI 0.04 to 1.06, low‐quality evidence), and similar numbers of participants ‐ nearly half ‐ from each treatment group left the study early (3 RCTs, n = 130, RR 1.21, 95% CI 0.83 to 1.77, low‐quality evidence). The risk of needing additional antiparkinsonian medication was less in the chlorpromazine group (2 RCTs, n = 74, RR 0.70, 95% CI 0.51 to 0.95). No useable data reported clinically important change in global or mental state. No data were reported for relapse. No deaths were reported by the trials. Authors' conclusions Only three small studies provided data and the quality of reporting and evidence is low. Limited data indicate the efficacy and adverse effects profiles of chlorpromazine and penfluridol are generally similar. Penfluridol, however, may confer advantage by needing to be given only once per week. Firm conclusions are not possible without good‐quality trials, and where these treatments are used, such trials are justified." @default.
• W1930217809 created "2016-06-24" @default.
• W1930217809 creator A5053782423 @default.
• W1930217809 creator A5055015849 @default.
• W1930217809 creator A5060431776 @default.
• W1930217809 date "2017-09-23" @default.
• W1930217809 modified "2023-09-25" @default.
• W1930217809 title "Chlorpromazine versus penfluridol for schizophrenia" @default.
• W1930217809 cites W1501619595 @default.
• W1930217809 cites W1533374633 @default.
• W1930217809 cites W1591259115 @default.
• W1930217809 cites W1787568865 @default.
• W1930217809 cites W1795981506 @default.
• W1930217809 cites W1897140431 @default.
• W1930217809 cites W1910485579 @default.
• W1930217809 cites W1930217809 @default.
• W1930217809 cites W1964162160 @default.
• W1930217809 cites W1970814820 @default.
• W1930217809 cites W1975753308 @default.
• W1930217809 cites W1975916217 @default.
• W1930217809 cites W1977185679 @default.
• W1930217809 cites W1978040764 @default.
• W1930217809 cites W1980862554 @default.
• W1930217809 cites W1981519638 @default.
• W1930217809 cites W1992857340 @default.
• W1930217809 cites W1999992635 @default.
• W1930217809 cites W2002527761 @default.
• W1930217809 cites W2003475832 @default.
• W1930217809 cites W2020844317 @default.
• W1930217809 cites W2023839473 @default.
• W1930217809 cites W2031036006 @default.
• W1930217809 cites W2032712358 @default.
• W1930217809 cites W2034643426 @default.
• W1930217809 cites W2057964653 @default.
• W1930217809 cites W2058874144 @default.
• W1930217809 cites W2067289350 @default.
• W1930217809 cites W2075153233 @default.
• W1930217809 cites W2080694991 @default.
• W1930217809 cites W2106848296 @default.
• W1930217809 cites W2115058221 @default.
• W1930217809 cites W2123255332 @default.
• W1930217809 cites W2125435699 @default.
• W1930217809 cites W2130235475 @default.
• W1930217809 cites W2135029321 @default.
• W1930217809 cites W2135494292 @default.
• W1930217809 cites W2145768745 @default.
• W1930217809 cites W2152689475 @default.
• W1930217809 cites W2157823046 @default.
• W1930217809 cites W2395403330 @default.
• W1930217809 cites W2405429602 @default.
• W1930217809 cites W2443596266 @default.
• W1930217809 cites W2462767734 @default.
• W1930217809 cites W2474551189 @default.
• W1930217809 cites W2516970163 @default.
• W1930217809 cites W3152326943 @default.
• W1930217809 cites W4230694669 @default.
• W1930217809 cites W4230700885 @default.
• W1930217809 cites W4250770703 @default.
• W1930217809 cites W4251553163 @default.
• W1930217809 cites W4299316111 @default.
• W1930217809 cites W4320288061 @default.
• W1930217809 cites W78683203 @default.
• W1930217809 cites W1675430428 @default.
• W1930217809 cites W2092641977 @default.
• W1930217809 doi "https://doi.org/10.1002/14651858.cd011831.pub2" @default.
• W1930217809 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6483663" @default.
• W1930217809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28940256" @default.
• W1930217809 hasPublicationYear "2017" @default.
• W1930217809 type Work @default.
• W1930217809 sameAs 1930217809 @default.
• W1930217809 citedByCount "11" @default.
• W1930217809 countsByYear W19302178092017 @default.
• W1930217809 countsByYear W19302178092018 @default.
• W1930217809 countsByYear W19302178092019 @default.
• W1930217809 countsByYear W19302178092020 @default.
• W1930217809 countsByYear W19302178092022 @default.
• W1930217809 countsByYear W19302178092023 @default.
• W1930217809 crossrefType "journal-article" @default.
• W1930217809 hasAuthorship W1930217809A5053782423 @default.
• W1930217809 hasAuthorship W1930217809A5055015849 @default.
• W1930217809 hasAuthorship W1930217809A5060431776 @default.
• W1930217809 hasBestOaLocation W19302178092 @default.
• W1930217809 hasConcept C118552586 @default.
• W1930217809 hasConcept C126322002 @default.
• W1930217809 hasConcept C17744445 @default.
• W1930217809 hasConcept C187212893 @default.
• W1930217809 hasConcept C197934379 @default.
• W1930217809 hasConcept C199539241 @default.
• W1930217809 hasConcept C27415008 @default.
• W1930217809 hasConcept C2776412080 @default.
• W1930217809 hasConcept C2778775820 @default.
• W1930217809 hasConcept C2779473830 @default.
• W1930217809 hasConcept C2779549880 @default.
• W1930217809 hasConcept C2780494398 @default.
• W1930217809 hasConcept C2781145037 @default.
• W1930217809 hasConcept C44249647 @default.
• W1930217809 hasConcept C535046627 @default.
• W1930217809 hasConcept C71924100 @default.
• W1930217809 hasConcept C82789193 @default.
• W1930217809 hasConcept C95190672 @default.

• next